006-b203901

A look at the day ahead in European and global markets. Sign up for Reuters newsletters Morning Bid Europe A look at the day ahead in European and global markets By Kevin Buckland, Correspondent   Data refreshes every time you open this email. For more European market news, click here . Please send any feedback to morningbid@thomsonreuters.com .   The marquee markets event for the week is almost upon us, and needs little introduction: The outlook for U.S. interest rates continues to be the elephant in the trading room for all asset classes, responsible not only for recent peaks in Treasury yields and the dollar, but also forming the backdrop for record runs and subsequent declines in the likes of gold and bitcoin.   The Federal Reserve wraps up its two-day powwow today with all ears trained on what Chair Jerome "Jay" Powell has to say in his new...

And, single antibody injection protects kids from malaria. Sign up for Reuters newsletters Health Rounds By Nancy Lapid , Health Science Editor Hello Health Rounds readers! Some benefits of newer diabetes treatments like Ozempic are still being discovered. They not only control blood sugar and help shed pounds , but we now find they may also lower the risk of liver cancer. We also report on an experimental antibody drug that appears to significantly reduce the risk of contracting symptomatic malaria, potentially addressing a large unmet need.       In breaking news, see these stories from our Reuters journalists:  Breast cancer screening should begin at age 40 ; US FDA tightens scrutiny of lab-developed tests ; U.S. state health plans must cover gender-affirming surgery ; Florida abortion clinics face uncertain future on eve of six-week limit ...